Related Experiment Videos
A model clinical program for patients with diabetes and vision impairment
The Diabetes Educator
|July 1, 1989
Summary
This program enhanced independence and self-esteem in visually impaired individuals with diabetes. Participants showed improved glycemic control and exercise tolerance after the 12-week intervention.
Area of Science:
- Endocrinology
- Ophthalmology
- Rehabilitation Medicine
Background:
- Diabetes mellitus is a chronic condition requiring lifelong self-management.
- Visual impairment presents unique challenges for individuals managing diabetes.
- Existing programs may not adequately address the combined needs of diabetes and blindness.
Purpose of the Study:
- To assess the effectiveness of a comprehensive 12-week program designed to improve independence, self-esteem, and glycemic control.
- To evaluate the impact of the program on psychosocial indices and physical functioning in visually impaired patients with diabetes.
Main Methods:
- A 12-week program involving education on diabetes self-management for the visually impaired, monitored exercise, and group support.
- Inclusion of 29 individuals with both insulin-dependent and non-insulin-dependent diabetes mellitus and visual impairment.
- Assessment of glycated hemoglobin, 12-minute walk test, Rand Mental Health Index, Rosenberg Self-Esteem Scale, Zung Depression Scale, and Diabetes Self-Reliance Test.
Main Results:
- Significant reduction in glycated hemoglobin from 13.0% to 11.4% (P = .001).
- Improved exercise tolerance, with a 12-minute walk test increase from 0.48 to 0.64 miles (P = .001).
- Marked improvements in psychosocial indices, including mental health, self-esteem, and reduced depression scores (P < .001 for all).
Conclusions:
- The 12-week program significantly improved glycemic control, exercise tolerance, and psychosocial well-being in patients with diabetes and blindness.
- The findings support the integration of specialized self-management education, exercise, and support for this population.
- This intervention demonstrates a viable approach to enhancing the quality of life and health outcomes for individuals with comorbid diabetes and visual impairment.